By continuing to use our site, you consent to the processing of cookies, user data (location information, type and version of the OS, the type and version of the browser, the type of device and the resolution of its screen, the source of where the user came from, from which site or for what advertisement, language OS and Browser, which pages are opened and to which buttons the user presses, ip-address) for the purpose of site functioning, retargeting and statistical surveys and reviews. If you do not want your data to be processed, please leave the site.

La voix des personnes atteintes d'un cancer du sein

Médias


2024

August 7, 2024: Canadian Breast Cancer Network Board Director, Cathy Ammendolea, speaks about the importance of breast cancer data collection and education for the Hill Times.
Read the op-ed directly on the Hill Times
Read the full op-ed text

July 16, 2024: Canadian Breast Cancer Network Board Director, Cathy Ammendolea, speaks about  the impact of breast cancer treatment on appearance for Fleetstreet magazine.
Read more

May 3, 2024: Canadian Breast Cancer Network Board Director, Cathy Ammendolea, speaks about how equity must be a priority in the Pharmacare Act for the Hill Times.
Read the op-ed directly on the Hill Times
Read the full op-ed text

January 27, 2024: Canadian Breast Cancer Network Board member, Quinn Obrigewitch, speaks to the Ottawa Citizen about TNBC .
Read more

January 9, 2024: Canadian Breast Cancer Network Board Director, Cathy Ammendolea, is interviewed for the Connect Collaborator Series.
Read more

2023

October 26, 2023: Canadian Breast Cancer Network Board Director, Cathy Ammendolea, comments on the HER CHOICE Digital Counselling Tool developed in collaboration with AstraZeneca and CONNECT Communications.
Read more

October 23, 2023: Canadian Breast Cancer Network's HR+ Patient Ambassador Jaclyn Carter and caregiver Alexander Grill-Donovan interviewed about breast cancer caregiver experiences.
Read more

October, 2023: Canadian Breast Cancer Network's TNBC Project launch editorial for Breast Cancer Awareness Month.
Read more

September 13, 2023: Canadian Breast Cancer Network Board Director Cathy Ammendolea comments on access to genetic testing in Canada.
Read more

February 23, 2023: The Canadian Breast Cancer Network calls on the Canadian Task Force to review breast screening guidelines based on current evidence.
Read more

January 27, 2023: The Canadian Breast Cancer Network comments on racial disparities in health and breast cancer-related data in Canada.
Read more

January 25, 2023: The Canadian Breast Cancer Network calls for more research and innovative treatments for metastatic breast cancer patients.
Read more

2022

December 7, 2022: The Canadian Breast Cancer Network, Rethink Breast Cancer, and the Canadian Cancer Society call on the Canadian Task Force of Preventative Health Care to reevaluate when women are screened for breast cancer.
Read more

2021

November 23, 2021: The Canadian Breast Cancer Network Report on Precision Oncology in Breast Cancer Highlights Gaps in Care.
Read more

October 26, 2021: The Canadian Breast Cancer Network, the Canadian Cancer Society, and Rethink Breast Cancer discuss an upcoming review of the breast screening environment
Read more

January 30, 2021: National Post discusses the importance of continuing cancer care during the COVID-19 pandemic. It highlights New Normal, Same Cancer, an initiative formed with various Canadian health charities, including CBCN
Read more

2020

September 2020: MediaPlanet highlights the work that Canadian Breast Cancer Network does for their Health Insights Campaign
Read more

June 23, 2020: For National Cancer Wellness Day, NATIONAL highlights the work that Canadian Breast Cancer Network does
Read more

2019

October 9, 2019: CTV News Coverage for mBC White Paper
Read more

May 7, 2019: "Biosimilars & Breast Cancer" White Paper Shares Recommendations From Physicians and Patients on the Use and Implementation of Biosimilars in Oncology
Read more

2015

October 13, 2015: The CBCN Releases New Report Identifying the Inequitable Access to Treatment for Women Living with Metastatic Breast Cancer
Read more

July 2015: Canadian Breast Cancer Network commends Québec Ministry of Health for commitment on metastatic breast cancer 
Read more

2014

October 22, 2014: Canadian Breast Cancer Network commends Ontario Ministry of Health for leadership on metastatic breast cancer
Read more

October 1, 2014: Canadian Breast Cancer Network Launches Living Legacy Campaign to Raise Awareness of Metastatic Breast Cancer
Read more

May 1, 2014: Hon. Hedy Fry introduces Bill acknowledging Metastatic Breast Cancer Day
Read more

April 4, 2014: Harper Government invests in new breast cancer awareness program
Read more

March 8, 2014: Living with metastatic breast cancer
Read more

January 30, 2014: La Vie en Rose Donates $5000 to the Canadian Breast Cancer Network
Read more

2013

December 2, 2013: The Canadian Breast Cancer Network Commends Provinces of Ontario, British Columbia, and Saskatchewan for Leadership on Metastatic Breast Cancer
Read more

October 15, 2013: Canadian Breast Cancer Network Calls for People Living with Metastatic Breast Cancer in Québec to Have Access to Life-saving Treatments
Read more

June 25, 2013: Remarkable New Report Reveals Unique Insight into the Perspectives of Canadian Women with Metastatic Breast Cancer
Read more

June 19, 2013: National Organizations Join Forces to Address Barriers to Breast Cancer Screening for Women with Disabilities and Deaf Women
Read more

May 17, 2013: Canadian Breast Cancer Network commends the province of Prince Edward Island for new catastrophic drug plan
Read more

April 3, 2013: Canadian Breast Cancer Network urges vigilant monitoring of chemotherapy drugs to promote patient safety
Read more

Our Journal Articles

Al, P., Hey, S., Weijer, C., Gillies, K., McCleary, N., Yee, M. L., Inglis, J., Presseau, J., & Brehaut, J. (2023). Changing patient preferences toward better trial recruitment: an ethical analysis. Trials, 24(1), 233. https://doi.org/10.1186/s13063-023-07258-4

Seung, S.J., Saherawala, H., Moldaver, D., Shokar, S., Ammendolea, C., Brezden-Masley, C. (2023). Survival, treatment patterns, and costs of HER2+ metastatic breast cancer patients in Ontario between 2005 to 2020. Breast Cancer Res Treathttps://doi.org/10.1007/s10549-023-07185-7

Brehaut, J. C., Carroll, K., Gordon, J., Presseau, J., Richards, D. P., Fergusson, D. A., Graham, I. D., et al. (2021). Results from a theory-guided survey to support breast cancer trial participation: Barriers, enablers, and what to do about them. Current Oncology28(3), 2014–2028.  http://dx.doi.org/10.3390/curroncol28030187

Cardoso, F., Wilking, N., Bernardini, R., Biganzoli, L., Espin, J., Miikkulainen, K., Schuurman, S., Spence, D., Spitz, S., Ujupan, S., Zernik, N., & Gordon, J. (2020). A multi-stakeholder approach in optimising patients’ needs in the benefit assessment process of new metastatic breast cancer treatments. The Breast, 52, 78-87https://doi.org/10.1016/j.breast.2020.04.011

Dent, S., Ammendolea, C., Christofides, A., Edwards, S., Incekol, D., Pourmirza, B., Kfoury, S., et al. (2019). A multidisciplinary perspective on the subcutaneous administration of trastuzumab in HER2-positive breast cancer. Current Oncology26(1), 70–80.  http://dx.doi.org/10.3747/co.26.4220